Search

Your search keyword '"Gaborit, Nathalie"' showing total 128 results

Search Constraints

Start Over You searched for: Author "Gaborit, Nathalie" Remove constraint Author: "Gaborit, Nathalie"
128 results on '"Gaborit, Nathalie"'

Search Results

1. Loss of Iroquois homeobox transcription factors 3 and 5 in osteoblasts disrupts cranial mineralization

Catalog

Books, media, physical & digital resources

7. FACS-assisted CRISPR-Cas9 genome editing of human induced pluripotent stem cells

8. Generation of three human induced pluripotent stem cell lines with IRX5 knockout and knockin genetic editions using CRISPR-Cas9 system

9. Generation of human induced pluripotent stem cell lines from three patients affected by Catecholaminergic Polymorphic ventricular tachycardia (CPVT) carrying heterozygous mutations in RYR2 gene

10. Iroquois homeobox gene 3 establishes fast conduction in the cardiac His–Purkinje network

12. Generation of human induced pluripotent stem cell lines from two patients affected by catecholamine-induced QT prolongation (CIQTP)

13. Generation of human induced pluripotent stem cell lines from four unrelated healthy control donors carrying European genetic background

14. Generation of three human induced pluripotent stem cell lines with IRX5 knockout and knockin genetic editions using CRISPR-Cas9 system

19. A consistent arrhythmogenic trait in Brugada syndrome cellular phenotype

20. Additional file 1 of In vitro differentiation of W8B2+ human cardiac stem cells: gene expression of ionic channels and spontaneous calcium activity

21. In vitro differentiation of W8B2 + human cardiac stem cells: gene expression of ionic channels and spontaneous calcium activity

22. Human model of IRX5 mutations reveals key role for this transcription factor in ventricular conduction

23. Human model of IRX5 mutations reveals key role for this transcription factor in ventricular conduction

25. Maurocalcin and its analog MCaE12A facilitate Ca2+ mobilization in cardiomyocytes

26. Functional Impact of BeKm-1, a High-Affinity hERG Blocker, on Cardiomyocytes Derived from Human-Induced Pluripotent Stem Cells

27. Human model of IRX5 mutations reveals key role for this transcription factor in ventricular conduction

31. RRAD mutation causes electrical and cytoskeletal defects in cardiomyocytes derived from a familial case of Brugada syndrome

32. Mental stress test: a rapid, simple, and efficient test to unmask long QT syndrome

33. HIV-Tat Induces a Decrease in I Kr and I Ks via Reduction in Phosphatidylinositol-(4,5)-Bisphosphate Availability

34. HIV-Tat induces a decrease in I Kr and I Ks via reduction in phosphatidylinositol-(4,5)-bisphosphate availability

35. A Molecular Substrate for Long QT in HIV Patients: Tat Protein Reduces IKR in Human Induced Pluripotent Stem Cells-Derived Cardiomyocytes

36. Toward Personalized Medicine: Using Cardiomyocytes Differentiated From Urine‐Derived Pluripotent Stem Cells to Recapitulate Electrophysiological Characteristics of Type 2 Long QT Syndrome

37. 0441 : Electrophysiological characterization of a novel SCN5A mutation causing Brugada syndrome, using cardiomyocytes differentiated from hiPSCs

40. Regional Ion Channel Gene Expression Heterogeneity and Ventricular Fibrillation Dynamics in Human Hearts

43. Transcriptional profiling of ion channel genes in Brugada syndrome and other right ventricular arrhythmogenic diseases

44. Human Atrial Ion Channel and Transporter Subunit Gene-Expression Remodeling Associated With Valvular Heart Disease and Atrial Fibrillation

45. Iroquois homeobox gene 3 establishes fast conduction in the cardiac His--Purkinje network.

46. Abstract 13258: Transcriptomic Remodeling of Brugada Syndrome Arises During in vitroCardiac Development

47. In vitro differentiation of W8B2+ human cardiac stem cells: gene expression of ionic channels and spontaneous calcium activity.

49. Generation of three human induced pluripotent stem cell lines with IRX5 knockout and knockin genetic editions using CRISPR-Cas9 system

50. A consistent arrhythmogenic trait in Brugada syndrome cellular phenotype